Financhill
Sell
28

SNN Quote, Financials, Valuation and Earnings

Last price:
$29.33
Seasonality move :
0.77%
Day range:
$29.86 - $30.18
52-week range:
$23.69 - $31.72
Dividend yield:
2.5%
P/E ratio:
32.09x
P/S ratio:
2.26x
P/B ratio:
2.49x
Volume:
634.4K
Avg. volume:
1.1M
1-year change:
5.77%
Market cap:
$13.1B
Revenue:
$5.8B
EPS (TTM):
$0.94

Analysts' Opinion

  • Consensus Rating
    Smith & Nephew PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $33.15, Smith & Nephew PLC has an estimated upside of 10.36% from its current price of $30.04.
  • Price Target Downside
    According to analysts, the lowest downside price target is $28.00 representing 100% downside risk from its current price of $30.04.

Fair Value

  • According to the consensus of 3 analysts, Smith & Nephew PLC has 10.36% upside to fair value with a price target of $33.15 per share.

SNN vs. S&P 500

  • Over the past 5 trading days, Smith & Nephew PLC has overperformed the S&P 500 by 0.25% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Smith & Nephew PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Smith & Nephew PLC has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Smith & Nephew PLC reported revenues of --.

Earnings Growth

  • Smith & Nephew PLC earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Smith & Nephew PLC reported earnings per share of --.
Enterprise value:
15.6B
EV / Invested capital:
--
Price / LTM sales:
2.26x
EV / EBIT:
23.46x
EV / Revenue:
2.69x
PEG ratio (5yr expected):
0.38x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
12.80x
Gross Profit (TTM):
$4B
Return On Assets:
4%
Net Income Margin (TTM):
7.09%
Return On Equity:
7.88%
Return On Invested Capital:
4.91%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2012-12-31 2013-12-31 2014-12-31 2013-12-31 2014-12-31
Income Statement
Revenue -- -- -- $1.2B $1.2B
Gross Profit -- -- -- $882M $940M
Operating Income -- -- -- $307M $372M
EBITDA -- -- -- $332M $353M
Diluted EPS -- -- -- $0.36 $0.36
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $4.7B $4.4B $3.9B $4B $4.4B
Total Assets $11B $10.9B $10B $10B $10.4B
Current Liabilities $1.7B $2.1B $1.7B $2.3B $1.5B
Total Liabilities $5.7B $5.4B $4.7B $4.8B $5.1B
Total Equity $5.3B $5.6B $5.3B $5.2B $5.3B
Total Debt $3.5B $3.1B $2.7B $2.9B $3.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2012-12-31 2013-12-31 2014-12-31 2013-12-31 2014-12-31
Cash Flow Statement
Cash Flow Operations -- -- -- $321M $302M
Cash From Investing -- -- -- -$199M $85M
Cash From Financing -- -- -- -$112M -$426M
Free Cash Flow -- -- -- -- --
SNN
Sector
Market Cap
$13.1B
$34.5M
Price % of 52-Week High
94.7%
49.05%
Dividend Yield
2.5%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
5.78%
-35.15%
Beta (5-Year)
0.689
0.615
Dividend yield:
2.5%
Annualized payout:
$0.75
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $30.28
200-day SMA
Buy
Level $27.41
Bollinger Bands (100)
Buy
Level 26.94 - 29.92
Chaikin Money Flow
Buy
Level 3.2M
20-day SMA
Buy
Level $29.88
Relative Strength Index (RSI14)
Buy
Level 52.22
ADX Line
Buy
Level 15.89
Williams %R
Neutral
Level -68.059
50-day SMA
Buy
Level $29.33
MACD (12, 26)
Buy
Level 7.49
25-day Aroon Oscillator
Buy
Level 56
On Balance Volume
Neutral
Level 3.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.0525)
Buy
CA Score (Annual)
Level (0.1244)
Buy
Beneish M-Score (Annual)
Level (-2.7631)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.373)
Buy
Piotroski F Score (Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Stock Forecast FAQ

In the current month, SNN has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The SNN average analyst price target in the past 3 months is $33.15.

  • Where Will Smith & Nephew PLC Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Smith & Nephew PLC share price will rise to $33.15 per share over the next 12 months.

  • What Do Analysts Say About Smith & Nephew PLC?

    Analysts are divided on their view about Smith & Nephew PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smith & Nephew PLC is a Sell and believe this share price will drop from its current level to $28.00.

  • What Is Smith & Nephew PLC's Price Target?

    The price target for Smith & Nephew PLC over the next 1-year time period is forecast to be $33.15 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is SNN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Smith & Nephew PLC is a Hold. 2 of 3 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of SNN?

    You can purchase shares of Smith & Nephew PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smith & Nephew PLC shares.

  • What Is The Smith & Nephew PLC Share Price Today?

    Smith & Nephew PLC was last trading at $29.33 per share. This represents the most recent stock quote for Smith & Nephew PLC. Yesterday, Smith & Nephew PLC closed at $30.04 per share.

  • How To Buy Smith & Nephew PLC Stock Online?

    In order to purchase Smith & Nephew PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Can SharkNinja Stock Go?
How High Can SharkNinja Stock Go?

If you know popular consumer appliance brands Shark and Ninja,…

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is down 3.26% over the past day.

Buy
72
MNPR alert for Jul 15

Monopar Therapeutics [MNPR] is down 8.6% over the past day.

Buy
56
NBIS alert for Jul 15

Nebius Group NV [NBIS] is up 2.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock